4AB:FRA
AbbVie Common Stock
€265.40
arrow_downward
-0.45%(-1.20) 1D
ኖቬም 18, 8:01:11 ጥዋት ጂ ኤም ቲ+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€265.40
High
€265.40
Low
€265.40
Mkt. cap
512.80 ቢ
Avg. vol.
109.00
Volume
0.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57 ሺ
Open
€265.40
High
€265.40
Low
€265.40
Mkt. cap
512.80 ቢ
Avg. vol.
109.00
Volume
0.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57 ሺ
News stories
From web sources and news partners
Investing.com
·
ከ1 ሰዓት በፊት
Abbvie stock price target raised to $349 by Piper Sandler on growth
Zacks Investment Research
·
ከ21 ሰዓቶች በፊት
How Did AbbVie's Neuroscience Franchise Perform in Q3?
The Globe and Mail
·
ከ1 ቀን በፊት
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
WSJ
·
ከ2 ሳምንታት በፊት
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 ሺ
Founded10 ኤፕሪ 2012
HeadquartersNorth Chicago, ኢሊኖይ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com